658 related articles for article (PubMed ID: 30481162)
1. Splicing factor SRSF1 promotes gliomagenesis via oncogenic splice-switching of MYO1B.
Zhou X; Wang R; Li X; Yu L; Hua D; Sun C; Shi C; Luo W; Rao C; Jiang Z; Feng Y; Wang Q; Yu S
J Clin Invest; 2019 Feb; 129(2):676-693. PubMed ID: 30481162
[TBL] [Abstract][Full Text] [Related]
2. Eucalyptal A inhibits glioma by rectifying oncogenic splicing of MYO1B mRNA via suppressing SRSF1 expression.
Hua D; Zhao Q; Yu Y; Yu H; Yu L; Zhou X; Wang Q; Sun C; Shi C; Luo W; Jiang Z; Wang W; Wang L; Zhang D; Tang S; Yu S
Eur J Pharmacol; 2021 Jan; 890():173669. PubMed ID: 33098832
[TBL] [Abstract][Full Text] [Related]
3. The RNA-binding protein SRSF1 is a key cell cycle regulator via stabilizing NEAT1 in glioma.
Zhou X; Li X; Yu L; Wang R; Hua D; Shi C; Sun C; Luo W; Rao C; Jiang Z; Wang Q; Yu S
Int J Biochem Cell Biol; 2019 Aug; 113():75-86. PubMed ID: 31200124
[TBL] [Abstract][Full Text] [Related]
4. SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes.
Song X; Wan X; Huang T; Zeng C; Sastry N; Wu B; James CD; Horbinski C; Nakano I; Zhang W; Hu B; Cheng SY
Cancer Res; 2019 Oct; 79(20):5288-5301. PubMed ID: 31462429
[TBL] [Abstract][Full Text] [Related]
5. Splicing factor SRSF1 promotes breast cancer progression via oncogenic splice switching of PTPMT1.
Du JX; Luo YH; Zhang SJ; Wang B; Chen C; Zhu GQ; Zhu P; Cai CZ; Wan JL; Cai JL; Chen SP; Dai Z; Zhu W
J Exp Clin Cancer Res; 2021 May; 40(1):171. PubMed ID: 33992102
[TBL] [Abstract][Full Text] [Related]
6. SRSF1 Prevents DNA Damage and Promotes Tumorigenesis through Regulation of DBF4B Pre-mRNA Splicing.
Chen L; Luo C; Shen L; Liu Y; Wang Q; Zhang C; Guo R; Zhang Y; Xie Z; Wei N; Wu W; Han J; Feng Y
Cell Rep; 2017 Dec; 21(12):3406-3413. PubMed ID: 29262322
[TBL] [Abstract][Full Text] [Related]
7. SRSF1-Regulated Alternative Splicing in Breast Cancer.
Anczuków O; Akerman M; Cléry A; Wu J; Shen C; Shirole NH; Raimer A; Sun S; Jensen MA; Hua Y; Allain FH; Krainer AR
Mol Cell; 2015 Oct; 60(1):105-17. PubMed ID: 26431027
[TBL] [Abstract][Full Text] [Related]
8. CircSMARCA5 Inhibits Migration of Glioblastoma Multiforme Cells by Regulating a Molecular Axis Involving Splicing Factors SRSF1/SRSF3/PTB.
Barbagallo D; Caponnetto A; Cirnigliaro M; Brex D; Barbagallo C; D'Angeli F; Morrone A; Caltabiano R; Barbagallo GM; Ragusa M; Di Pietro C; Hansen TB; Purrello M
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29415469
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA DGCR5 involves in tumorigenesis of esophageal squamous cell carcinoma via SRSF1-mediated alternative splicing of Mcl-1.
Duan Y; Jia Y; Wang J; Liu T; Cheng Z; Sang M; Lv W; Qin J; Liu L
Cell Death Dis; 2021 Jun; 12(6):587. PubMed ID: 34099633
[TBL] [Abstract][Full Text] [Related]
10. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.
Wang H; Yan X; Ji LY; Ji XT; Wang P; Guo SW; Li SZ
Technol Cancer Res Treat; 2017 Aug; 16(4):497-511. PubMed ID: 26868851
[TBL] [Abstract][Full Text] [Related]
11. SRSF1 modulates PTPMT1 alternative splicing to regulate lung cancer cell radioresistance.
Sheng J; Zhao Q; Zhao J; Zhang W; Sun Y; Qin P; Lv Y; Bai L; Yang Q; Chen L; Qi Y; Zhang G; Zhang L; Gu C; Deng X; Liu H; Meng S; Gu H; Liu Q; Coulson JM; Li X; Sun B; Wang Y
EBioMedicine; 2018 Dec; 38():113-126. PubMed ID: 30429088
[TBL] [Abstract][Full Text] [Related]
12. High expression of SRSF1 facilitates osteosarcoma progression and unveils its potential mechanisms.
Li S; Huang X; Zheng S; Zhang W; Liu F; Cao Q
BMC Cancer; 2024 May; 24(1):580. PubMed ID: 38735973
[TBL] [Abstract][Full Text] [Related]
13. A SRSF1 self-binding mechanism restrains Mir505-3p from inhibiting proliferation of neural tumor cell lines.
Yang K; Tong L; Li K; Zhou Y; Xiao J
Anticancer Drugs; 2018 Jan; 29(1):40-49. PubMed ID: 29120871
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of alternative splicing contributes to multiple myeloma pathogenesis.
Song S; Zhang W; Li Q; Wang Z; Su Q; Zhang X; Li B; Zhuang W
Br J Cancer; 2023 Apr; 128(6):1086-1094. PubMed ID: 36593359
[TBL] [Abstract][Full Text] [Related]
15. SRSF1 is essential for primary follicle development by regulating granulosa cell survival via mRNA alternative splicing.
Yao X; Wang C; Yu W; Sun L; Lv Z; Xie X; Tian S; Yan L; Zhang H; Liu J
Cell Mol Life Sci; 2023 Oct; 80(11):343. PubMed ID: 37907803
[TBL] [Abstract][Full Text] [Related]
16. Splicing Factor SRSF1 Promotes Pancreatitis and KRASG12D-Mediated Pancreatic Cancer.
Wan L; Lin KT; Rahman MA; Ishigami Y; Wang Z; Jensen MA; Wilkinson JE; Park Y; Tuveson DA; Krainer AR
Cancer Discov; 2023 Jul; 13(7):1678-1695. PubMed ID: 37098965
[TBL] [Abstract][Full Text] [Related]
17. Altered VEGF Splicing Isoform Balance in Tumor Endothelium Involves Activation of Splicing Factors Srpk1 and Srsf1 by the Wilms' Tumor Suppressor Wt1.
Wagner KD; El Maï M; Ladomery M; Belali T; Leccia N; Michiels JF; Wagner N
Cells; 2019 Jan; 8(1):. PubMed ID: 30641926
[TBL] [Abstract][Full Text] [Related]
18. The SRSF1/circATP5B/miR-185-5p/HOXB5 feedback loop regulates the proliferation of glioma stem cells via the IL6-mediated JAK2/STAT3 signaling pathway.
Zhao J; Jiang Y; Zhang H; Zhou J; Chen L; Li H; Xu J; Zhang G; Jing Z
J Exp Clin Cancer Res; 2021 Apr; 40(1):134. PubMed ID: 33858489
[TBL] [Abstract][Full Text] [Related]
19. The role of transcriptional coactivator TAZ in gliomas.
Li W; Dong S; Wei W; Wang G; Zhang A; Pu P; Jia Z
Oncotarget; 2016 Dec; 7(50):82686-82699. PubMed ID: 27764783
[TBL] [Abstract][Full Text] [Related]
20. Serine Arginine-Rich Splicing Factor 1 (SRSF1) Contributes to the Transcriptional Activation of CD3ζ in Human T Cells.
Moulton VR; Gillooly AR; Perl MA; Markopoulou A; Tsokos GC
PLoS One; 2015; 10(7):e0131073. PubMed ID: 26134847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
